This website is intended for healthcare professionals only

Trending Topic

31 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Ventricular fibrillation (VF) is characterized by rapid (>300 beats a per minute), irregular electrical activation with variable electrocardiographic waveforms that prevents coordinated myocardial contraction, resulting in immediate loss of cardiac output.1 It most commonly occurs in the context of coronary artery disease.2,3 Resuscitation efforts are critically time-dependent: with each minute of untreated VF, the survival rate declines […]

Prakash Deedwania, C3 2019 – Recent Data on Cardiovascular Outcomes and Novel Diabetes Medications

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 5th 2019

We spoke to Dr Prakash Deedwania (School of Medicine, University of California, San Francisco, San Francisco, CA, USA) at C3 2019 about recent findings and trial outcomes relating to diabetic treatments and improved outcomes and possible cardioprotective effects for cardiology patients.

Speaker’s Disclosures: Prakash Deedwania has nothing to declare in relation to this video interview.

Questions:
1. Some studies around diabetes treatments have demonstrated improved outcomes and potential cardioprotective effects; what do you think have been the most important findings? (0:04)

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup